Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL):...

Value in Health 2015 / 05 Vol. 18; Iss. 3

Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL): evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 study

Rule, S., Goy, A., Martin, P., Ramchandren, R., Alexeeva, J., Popat, R., Avivi, I., Advani, R., Le Gouill, S., Horowitz, N., Yuan, Z., Kranenburg, B., Zhuang, S.H., Deraedt, W., Rizo, A., Wildgust, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.03.1750
Date:
May, 2015
File:
PDF, 71 KB
english, 2015
Conversion to is in progress
Conversion to is failed